‘Critical Step’ For Petros Toward ED Switch Proposal With OTC Label Comprehension Study

 
• By Malcolm Spicer

Firm reports “significant comprehension” among 480 participants. It also expects DFL technology it’s developing for potential OTC sales of Stendra ED drug could be used for other OTC switch proposals.

Petros Pharmaceuticals anticipates Drug Facts label technology it’s developing for potential switch of its Stendra ED drug also could be used for other OTC switch proposals. • Source: Petros Pharmaceuticals

More from Rx-to-OTC Switch

More from Health